Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 22, 2021
Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis.
Journal: Clinical pharmacokinetics
Published: December 05, 2020
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Journal: American journal of clinical dermatology
Published: May 22, 2019
Design and Conduct Considerations for First-in-Human Trials.
Journal: Clinical and translational science
Published: April 16, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
Journal: Journal of the American Academy of Dermatology
Published: March 20, 2018
Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult Subjects.
Journal: Clinical pharmacology in drug development
Published: May 02, 2016
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib.
Journal: Journal of clinical pharmacology
Published: November 30, 2015
Evaluation of the effect of food and gastric pH on the single-dose pharmacokinetics of cabozantinib in healthy adult subjects.
Journal: Journal of clinical pharmacology
Published: February 10, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026